Schnabel R, Dalmi L, Sipka S, Bokor M, Malatinszky G, Garam T
2nd Department of Medicine, Róbert Károly Hospital, Budapest, Hungary.
Acta Med Hung. 1991;48(1-2):23-31.
The aim of our present study was to examine the ADCC reaction against liver cell in various chronic liver diseases on the basis of indirect evidence. Forty-nine liver patients and one hundred and twenty-three healthy controls were examined. Anti-LSP autoantibody was determined on rat liver membrane by using the indirect immunofluorescent method. On the other hand, Killer-cell activity against human erythrocyte target cells was established in the lymphocytes of peripheral blood. Anti-LSP autoantibodies were demonstrated in seven patients and were associated with the high Killer-cell activity in six cases. Specific ADCC reaction to liver cell membrane can be assumed if anti-LSP autoantibody presence is topped with increased Killer-cell activity.
我们目前这项研究的目的是基于间接证据来检测各种慢性肝病中针对肝细胞的抗体依赖细胞介导的细胞毒性反应(ADCC反应)。研究对49例肝病患者和123名健康对照者进行了检测。采用间接免疫荧光法测定大鼠肝细胞膜上的抗肝特异性脂蛋白(LSP)自身抗体。另一方面,对外周血淋巴细胞中针对人红细胞靶细胞的杀伤细胞活性进行了测定。在7例患者中检测到抗LSP自身抗体,其中6例与高杀伤细胞活性相关。如果抗LSP自身抗体的存在伴随着杀伤细胞活性的增加,则可推测存在对肝细胞膜的特异性ADCC反应。